Orthofix Medical, Inc. (NASDAQ:OFIX) Q3 2022 Earnings Conference Call November 3, 2022 8:30 AM ET
Company Participants
Alexa Huerta - Senior Director, IR
Jon Serbousek - President, CEO & Director
Douglas Rice - CFO & CAO
Conference Call Participants
David Turkaly - JMP Securities
Mathew Blackman - Stifel, Nicolaus & Company
Jeffrey Cohen - Ladenburg Thalmann & Co.
James Sidoti - Sidoti & Company
Operator
Good morning. My name is Gavin and I will be your conference operator today. At this time, I would like to welcome everyone to the Orthofix Medical Third Quarter Earnings Conference Call. [Operator Instructions]. Alex Huerta you may now begin your conference.
Alexa Huerta
Thank you, operator, and good morning, everyone. Welcome to the Orthofix Third Quarter 2022 Earnings Call. Joining me on the call today are our President and Chief Executive Officer, Jon Serbousek; and Chief Financial Officer, Doug Rice. I'll start with the safe harbor statement and then pass it over to Jon. During this call, we will be making forward-looking statements that involve risks and uncertainties. All statements other than those of historical facts are forward-looking statements, including any earnings guidance we provide and any statements about our plans, beliefs, strategies, expectations, goals or objectives. Investors are cautioned not to place undue reliance on such forward-looking statements as there is no assurance that the matter contained in such statements will occur. The forward-looking statements we will make on today's call are based on our beliefs and expectations as of today, November 3, 2022. We do not take any obligation to revise or update such forward-looking statements. Some factors that could cause actual results to be materially different from the forward-looking statements made by us on the call include the risk factors disclosed under the heading Risk Factors in our Form 10-K for the year ended December 31, 2021 and Form 10-Q for the quarter ended September 30, 2022, filed this morning, November 3, 2022, as well as additional SEC filings we make in the future. If you need copies of these documents, please contact my office at Orthofix in Lewisville, Texas.
In addition, on today's call, we will refer to various non-GAAP financial measures. We believe that in order to properly understand our short-term and long-term financial trends, investors may wish to review these matters as a supplement to the financial measures determined in accordance with U.S. GAAP. Please refer to today's press release announcing our third quarter 2022 results for reconciliations of these non-GAAP financial measures to our U.S. GAAP financial results. At this point, I will turn the call over to Jon.